Wanwan Yi

407 total citations
22 papers, 276 citations indexed

About

Wanwan Yi is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Wanwan Yi has authored 22 papers receiving a total of 276 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Wanwan Yi's work include MicroRNA in disease regulation (3 papers), Peptidase Inhibition and Analysis (3 papers) and Cancer-related molecular mechanisms research (3 papers). Wanwan Yi is often cited by papers focused on MicroRNA in disease regulation (3 papers), Peptidase Inhibition and Analysis (3 papers) and Cancer-related molecular mechanisms research (3 papers). Wanwan Yi collaborates with scholars based in China, Cuba and Hong Kong. Wanwan Yi's co-authors include Hengwei Fan, Shige Wang, Yu Zhang, Hang Wu, Jiulong Zhao, Ting Wang, Hengwei Fan, Lissette Agüero, Dionisio Zaldívar and Zheng Chen and has published in prestigious journals such as The FASEB Journal, Gene and Biosensors and Bioelectronics.

In The Last Decade

Wanwan Yi

20 papers receiving 273 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wanwan Yi China 8 92 86 56 48 39 22 276
Artem A. Trotsyuk United States 11 129 1.4× 203 2.4× 61 1.1× 79 1.6× 78 2.0× 26 415
Dharshan Sivaraj United States 11 92 1.0× 146 1.7× 136 2.4× 59 1.2× 79 2.0× 35 423
Shaobin Huang China 11 117 1.3× 206 2.4× 88 1.6× 51 1.1× 102 2.6× 26 444
Yasuhiko Okamura Japan 12 131 1.4× 45 0.5× 112 2.0× 37 0.8× 55 1.4× 42 472
Zicheng Zeng China 9 64 0.7× 43 0.5× 120 2.1× 49 1.0× 69 1.8× 16 367
Erin P. Sproul United States 9 100 1.1× 74 0.9× 41 0.7× 64 1.3× 76 1.9× 9 317
Daniel B. Rodrigues Portugal 10 105 1.1× 107 1.2× 64 1.1× 66 1.4× 57 1.5× 20 360
Milena Deptuła Poland 12 84 0.9× 86 1.0× 123 2.2× 73 1.5× 61 1.6× 32 404
Abudula Abududilibaier China 6 134 1.5× 199 2.3× 73 1.3× 64 1.3× 114 2.9× 7 462

Countries citing papers authored by Wanwan Yi

Since Specialization
Citations

This map shows the geographic impact of Wanwan Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanwan Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanwan Yi more than expected).

Fields of papers citing papers by Wanwan Yi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wanwan Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanwan Yi. The network helps show where Wanwan Yi may publish in the future.

Co-authorship network of co-authors of Wanwan Yi

This figure shows the co-authorship network connecting the top 25 collaborators of Wanwan Yi. A scholar is included among the top collaborators of Wanwan Yi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wanwan Yi. Wanwan Yi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Xiaqing, et al.. (2025). Gut microbiota alteration was related to subclinical hypothyroidism and dyslipidemia in mice. The FASEB Journal. 39(5). e70445–e70445. 1 indexed citations
2.
Ji, Baohua, Qing Yang, Jingyi Sun, et al.. (2025). Targeted molecular rapid SERS diagnosis in clinical human serum through aptamer origami-collapsed nanofingers chip. Biosensors and Bioelectronics. 285. 117583–117583. 10 indexed citations
4.
Tian, Tongguan, Wanwan Yi, Yixin Xu, et al.. (2023). FBXO38 mediates FGL1 ubiquitination and degradation to enhance cancer immunity and suppress inflammation. Cell Reports. 42(11). 113362–113362. 13 indexed citations
6.
Yi, Wanwan, Zheng Chen, Hengwei Fan, et al.. (2023). Highly absorbent bio-sponge based on carboxymethyl chitosan/poly-γ-glutamic acid/platelet-rich plasma for hemostasis and wound healing. International Journal of Biological Macromolecules. 247. 125754–125754. 55 indexed citations
8.
Liu, Xiaoyan, Wen Jiang, Tingting Qiao, et al.. (2023). The Potential Role of Pyrroloquinoline Quinone to Regulate Thyroid Function and Gut Microbiota Composition of Graves’ Disease in Mice. Polish Journal of Microbiology. 72(4). 443–460. 3 indexed citations
9.
Long, Xuan, Jie Zhang, Jia Chen, et al.. (2023). Employment Intention of Chinese Medical Students During the COVID-19 Epidemic: A Cross-Sectional Survey.. PubMed. 29(2). 191–199. 3 indexed citations
10.
Wang, Ting, Wanwan Yi, Yu Zhang, et al.. (2022). Sodium alginate hydrogel containing platelet-rich plasma for wound healing. Colloids and Surfaces B Biointerfaces. 222. 113096–113096. 120 indexed citations
11.
Yi, Wanwan, Tingting Qiao, Ziyu Yang, et al.. (2022). The regulation role and diagnostic value of fibrinogen-like protein 1 revealed by pan-cancer analysis. Materials Today Bio. 17. 100470–100470. 7 indexed citations
12.
Zhang, Jie, Jia Chen, Xuan Li, et al.. (2022). Analyzing the influence of COVID-19 epidemic on the employment intention of resident physicians in China. The Journal of Infection in Developing Countries. 16(6). 1009–1015.
13.
Fan, Hengwei, et al.. (2022). Roles of BMI1 in the Initiation, Progression, and Treatment of Hepatocellular Carcinoma. Technology in Cancer Research & Treatment. 21. 2203812577–2203812577. 15 indexed citations
14.
Yi, Wanwan, Jin Liu, Zichen Chen, et al.. (2021). Risk factors for recurrent positive results of the nucleic acid amplification test for COVID-19 patients: a retrospective study. Human Cell. 34(6). 1744–1754. 2 indexed citations
15.
Qu, Shuping, et al.. (2020). Weighted Gene Coexpression Network Analysis Reveals the Dynamic Transcriptome Regulation and Prognostic Biomarkers of Hepatocellular Carcinoma. Evolutionary Bioinformatics. 16. 1612666866–1612666866. 3 indexed citations
16.
Yi, Wanwan, et al.. (2020). An 8 miRNA-Based Risk Score System for Predicting the Prognosis of Patients With Papillary Thyroid Cancer. Technology in Cancer Research & Treatment. 19. 1079233242–1079233242. 7 indexed citations
17.
Fan, Hengwei, Xiaqing Yu, Xiaohui Fu, et al.. (2020). Clinical implications of different specimen types for nucleic acid testing in two cases of COVID-19. Journal of International Medical Research. 48(8). 1220748619–1220748619. 3 indexed citations
18.
Zhang, Han, Shanshan Qin, Jiajia Zhang, et al.. (2019). The expression and clinical significance of secretory leukocyte proteinase inhibitor (SLPI) in mammary carcinoma using bioinformatics analysis. Gene. 720. 144088–144088. 8 indexed citations
19.
Zhang, Yijun, Shuping Qu, Wanwan Yi, et al.. (2019). A Pretreatment CT Model Predicts Survival Following Chemolipiodolization in Patients With Hepatocellular Carcinoma. Technology in Cancer Research & Treatment. 18. 1078112136–1078112136. 3 indexed citations
20.
Zhang, Chao, Hengwei Fan, Wanwan Yi, & Zhiqiang Zheng. (2017). Hidden Blood Loss and Its Influential Factors After Laparoscopy-Assisted Gastrectomy for Gastric Cancer. Journal of Laparoendoscopic & Advanced Surgical Techniques. 28(3). 237–241. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026